cell-therapy Videos
35 videos found
In laying the groundwork for the future of cell therapies, CMaT engages a diverse range of stakeholders worldwide, from various backgrounds, and with distinct perspectives. ...
Jun. 2, 2022
Rethink Cell Therapy with Lipid Nanoparticles. Available April 16, 2021 The GenVoy-ILM T Cell Kit for mRNA is an LNP reagent mix optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr® Spark™ instrument and cartridges. It can be used at various stages of ...
Oct. 5, 2021
We have human Trophoblast Stem Cells. Contact us for collaboration for new cell ...
Jun. 3, 2022
Amish Raval of the University of Wisconsin - Madison talks about the CardiAMP cell therapy and the pivotal phase III CardiAMP Heart Failure ...
May. 31, 2022
A quick overview of C-Stem™, the patented technology operated by TreeFrog Therapeutics to mass-produce stem cells for cell ...
Jul. 13, 2022
Educational video about ischemic heart failure, current treatment options, and the potential of cell therapy as an alternative treatment option for ...
May. 31, 2022
Educational video about the CardiAMP Cell Therapy and the cardiac catheterization procedure required to inject the cells into the ...
May. 31, 2022
TreeFrog Therapeutics is a stem cell company based in Bordeaux, France, that will enable millions of patients to access the medical revolution of cell therapy by overcoming its main manufacturing ...
Jul. 13, 2022
At our Research facility in the UK, near Oxford, teams are working to design and develop our next generation cell therapy products to treat patients with cancer. ...
May. 6, 2021
Highlighting the progress made by Kris Boesen and Lucas Lindner, both of whom received Lineage's OPC1 cell therapy following traumatic spinal cord injury ...
Jul. 15, 2022
Cell therapy company TreeFrog Therapeutics is powering The Stem Cell SpaceShot Grant - a $100,000 research funding in the field of stem cell biology and regenerative medicine. It’s open to PhD-level scientists and PhD students conducting research in stem cell biology, biophysics, gene editing, ...
Jul. 13, 2022
IDCT is an investigational allogeneic (donor-derived), injectable (non-surgical) cell therapy that utilizes proprietary Discogenic Cells to treat degenerative disc ...
Sep. 1, 2021
Incorporated in Bordeaux, France, in 2018, TreeFrog Therapeutics aims to provide access to safe and affordable cell therapies for millions of patients. TreeFrog Therapeutics has developed C-Stem™, a high-throughput cell encapsulation technology allowing for the mass-production and differentiation of stem cells in industrial ...
Jul. 13, 2022
The company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases not adequately addressed by current therapeutics. ...
Jun. 6, 2022
Malibu, a white German shepherd, had arthritis that was treated with stem-cell therapy, regenerative medicine. Stem cells are extracted from the animal's own fat. ...
Jun. 2, 2022
Carina Biotech and AdAlta are collaborating to develop precision engineered CAR-T cell therapies that provide new hope for patients. AdAlta and Carina Biotech experts; Dr Deborah Rathjen, Carina Biotech CEO & Managing Director, Dr Tim Oldham, AdAlta CEO & Managing Director, Professor Shaun McColl, Vice President Chemokine Platform Technology at Carina Biotech, ...
Feb. 14, 2023
Carina Biotech and AdAlta are collaborating to develop precision engineered CAR-T cell therapies that provide new hope for patients. AdAlta and Carina Biotech experts; Dr Deborah Rathjen, Carina Biotech CEO & Managing Director, Dr Tim Oldham, AdAlta CEO & Managing Director, Professor Shaun McColl, Vice President Chemokine Platform Technology at Carina Biotech, ...
Jun. 3, 2022
An instructive whiteboard video explaining how spinal cord injury disrupts normal bodily function as well as OPC1 administration and mechanism of ...
Jul. 15, 2022
Racheli Ofir, VP Research & Intellectual Property, sharing insights on PLX-R18’s unique mechanism of action and therapeutic potential for the treatment of hematology deficiencies. Pluristem’s PLX R-18 cell therapy has the potential to generate improved blood counts in all three blood cell lineages. ...
May. 31, 2022
Pluristem's cell manufacturing technology - PLX Bioreactor 3D system, is integrated into the world’s most advanced, automated and aseptic cell production facility, in which we can manufacture large quantities of cells of the highest quality in a cost-effective, reproducible and consistent manner. This capability is necessary for any ...
May. 31, 2022